Sentence examples for high dose treated from inspiring English sources
The human liposarcoma animal model showed tumor size was decreased approximately 36% in high dose treated group (Fig. 4C).
Similarly, in DAPT high dose treated embryos, in which Notch signaling is mostly if not completely blocked, srn did not add to the defects caused by DAPT alone, i.e. DAPT treated srn mutants resembled DAPT treated WT embryos showing similar reduced Zn5+ cells and GFAP+ glial cells in the spinal cord (Fig. 5).
Collectively, a likely explanation is that the local immunomodulatory environment in the high dose treated animals is causing local antigen presenting cells to have a less activated phenotype, so that when they migrate to the draining lymph nodes, the T-cells are not as activated and perhaps more anergic or tolerant.
High dose treated group, mice (p.o).
However, SCEE high dose treated group showed no significant difference in comparison to glibenclamide treated group.
SCEE demonstrated dose dependent alterations and high dose treated group showed very low glucose concentration when compared to the pretreated blood glucose level (0 min) (Table 1).
The splenic architecture of the high-dose treated groups showed well-maintained capsule, clearly demarcated white and red pulp and with adjoining trabecular all over the tissues.
In comparison, low-dose and high-dose treated animals had 1.30 µg/ml to 6.63 µg/ml of free genistein, respectively.
Each of these hyperphosphorylated residues has been previously associated with aggregated hyperphosphorylated tau in AD [32], and in the high-dose treated sod2 null animals, we observed a significant normalization of phosphorylation toward wild-type levels of phosphorylation in 3 out of 4 residues which were hyperphosphorylated (Figure 1).
In our study 41% of the patients reported concentration problems during tamoxifen use, however equally distributed over standard-dose and high-dose treated patients.
The risk of cognitive impairment with high-dose treated patients was 8.2 times higher than in breast cancer patients not receiving systemic therapy and 3.5 times higher than in standard-dose treated patients.
